Key Takeaways On Feb. 6, 2026, FDA announced that it would take action to restrict access to GLP-1 ingredients for non-FDA ...
Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...
Danaher has undergone a radical transformation from a real estate trust to a leader in the life sciences industry through strategic acquisitions. The company's focus on continuous improvement and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results